MoonLake Immunotherapeutics (MLTX) — Defensive Interval Ratio
MoonLake Immunotherapeutics (MLTX) has a Defensive Interval Ratio of 516 days as of March 2026. Defensive assets of $65.19 Million (cash $-, short-term investments $59.43 Million, receivables $5.76 Million) cover 516 days of daily cash needs of $126.34K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
MoonLake Immunotherapeutics Defensive Interval Ratio (2021–2025)
This chart shows how MoonLake Immunotherapeutics's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 516 days, meaning defensive assets of $65.19 Million can fund 516 days of operations without new revenue. For the complete balance sheet picture, see MLTX current and non-current assets.
Annual Defensive Interval Ratio for MoonLake Immunotherapeutics (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for MoonLake Immunotherapeutics from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See how liquid is MoonLake Immunotherapeutics's working capital to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 516 days | $64.32 Million | $124.60K/day | $- | $59.45 Million | ▼ -3878 days |
| 2024 | 4394 days | $270.44 Million | $61.54K/day | $- | $267.60 Million | ▲ +2164 days |
| 2023 | 2230 days | $60.90 Million | $27.30K/day | $- | $59.84 Million | ▲ +667 days |
| 2022 | 1563 days | $32.83 Million | $21.00K/day | $- | $32.61 Million | ▲ +1560 days |
| 2021 | 3 days | $148.77K | $57.77K/day | $- | $0.00 | — |